Pyrazole Derivatives as Cannabinoid Receptor 1 Antagonists
The invention provides compounds capable of acting as antagonists at cannabanoid receptors according to the following formula; Such compounds may be used to treat conditions for which the cannabinoid receptor system has been implicated, such as obesity, liver disease, diabetes, pain, and inflammation.
Citation
Fulp, A., Maitra, R., Zhang, Y., & Seltzman, H. (2015). IPC No. U.S. Pyrazole Derivatives as Cannabinoid Receptor 1 Antagonists. (Patent No. 9133128).